Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1

Aberrant NMDA receptor (NMDAR) activity contributes to several neurological disorders, but direct antagonism is poorly tolerated therapeutically. The GluN2B cytoplasmic C-terminal domain (CTD) represents an alternative therapeutic target since it potentiates excitotoxic signaling. The key GluN2B CTD...

Descripción completa

Detalles Bibliográficos
Autores principales: McQueen, Jamie, Ryan, Tomás J, McKay, Sean, Marwick, Katie, Baxter, Paul, Carpanini, Sarah M, Wishart, Thomas M, Gillingwater, Thomas H, Manson, Jean C, Wyllie, David J A, Grant, Seth G N, McColl, Barry W, Komiyama, Noboru H, Hardingham, Giles E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544426/
https://www.ncbi.nlm.nih.gov/pubmed/28731405
http://dx.doi.org/10.7554/eLife.17161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544426/
https://www.ncbi.nlm.nih.gov/pubmed/28731405
http://dx.doi.org/10.7554/eLife.17161

Ejemplares similares